Abstract:Esophageal cancer (EC), including esophageal squamous cell carcinoma (ESCC) and adenocarcinoma (EAC), is one of the deadliest cancers with extremely aggressive nature and poor survival rate. Diagnostic methods for EC mainly include endoscopy, barium swallow and ultrasound, which are either invasive or lack of sensitivity and specificity at early stages. Therefore, the development of a non-invasive and reliable diagnostic method with high sensitivity and specificity is crucial in improving early detection, diagnosis and treatment. microRNAs (miRNAs) are small RNA molecules that regulate the expression of protein-coding genes by directly binding to target mRNAs in a sequence-specific manner. The aim of this study is to identify novel miRNA biomarkers for EC diagnosis. By cross-referencing our data with others’ from NCBI, we identified a list of dysregulated miRNAs in EC, including miR-375. We assessed the expression of miR-375 in EC cell lines and tissues using real-time reverse transcriptase-polymerase chain reaction (qRT-PCR). We found that miR-375 expression is significantly decreased in human EC cell lines (KEYS-70, KEYS-180, FLO-1 and JHU-ad1) compared to the normal esophageal squamous cell line, Het-1A. Using microdissection technique, we isolated normal epithelium, dysplasia, and invasive EC components from formalin-fixed, paraffin-embedded (FFPE) tissue followed by qRT-PCR analysis. Decreased expression of miR-375 was detected in 12 of 14 EC tissue samples (86%) compared to the matched normal tissues. MTT and Matrigel invasion assay demonstrated that forced expression of miR-375 suppressed the proliferation and invasion in EC cell lines. TargetScanS and miRanda were used to identify potential target genes of miR-375, which includes epidermal growth factor receptor 2 (HER2) and YES-associated protein (YAP1), both of them act as oncogenes in EC development. Interestingly, forced expression of miR-375 resulted in significantly reduced expression of human vascular endothelial growth factor-A (VEGF-A) gene, which is a downstream target gene of YAP1/ERBB2 pathway involving in tumor angiogenesis in EC cell lines. More functional analysis is under way. These findings suggest that miR-375 may act as a tumor suppressor, and could serve as a marker for EC diagnosis and management. Citation Format: Shuchang Ren, Xiaohui Tan, Xiaoling Wu, Tao Chen, Patricia Latham, Sidney W. Fu. miR-375 downregulates VEGFA via YAP1-EBRR2 pathway in esophageal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 783.

MiR-195-5p Reduces Esophageal Cancer Cell Proliferation Through The IGF-1R/AKT Axis

MiRNA-485-5p, Inhibits Esophageal Cancer Cells Proliferation and Invasion by Down-Regulating O-linked N-acetylglucosamine Transferase.

Mir-195 Regulates Proliferation and Apoptosis Through Inhibiting the Mtor/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.

Inhibition of Mir-196A Affects Esophageal Cancer Cell Growth in Vitro.

MiR-196a promotes the proliferation and migration of esophageal cancer via the UHRF2/TET2 axis

Cancer-associated Fibroblast-Released Extracellular Vesicles Carrying Mir-199A-5p Induces the Progression Of Gastric Cancer Through Regulation of FKBP5-mediated AKT1/mTORC1 Signaling Pathway.

MicroRNA-155 Inversely Correlates with Esophageal Cancer Progression Through Regulating Tumor-Associated Macrophage FGF2 Expression.

Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK)

MiR-3682-3p promotes esophageal cancer progression by targeting FHL1 and activating the Wnt/β-catenin signaling pathway

The expression of miR-195 in esophageal cancer and its effect on proliferation of esophageal cancer cell lines

Increased Mir-203-3p and Reduced Mir-21-5p Synergistically Inhibit Proliferation, Migration, and Invasion in Esophageal Cancer Cells

MiR-19 b promotes growth and migration of human esophageal squamous cell carcinoma Eca 109 cells by negatively regulating PTEN

MiR-495 Inhibits Esophageal Squamous Cell Carcinoma Progression by Targeting Akt1.

Abstract 783: Mir-375 Downregulates VEGFA Via YAP1-EBRR2 Pathway in Esophageal Cancer

Mirna‑30a‑3p Inhibits Metastasis and Enhances Radiosensitivity in Esophageal Carcinoma by Targeting Insulin‑like Growth Factor 1 Receptor.

Differential Expression of Mir-195 in Esophageal Squamous Cell Carcinoma and Mir-195 Expression Inhibits Tumor Cell Proliferation and Invasion by Targeting of Cdc42.

MicroRNA-2053 involves in the progression of esophageal cancer by targeting KIF3C

miR-28-5p targets MTSS1 to regulate cell proliferation and apoptosis in esophageal cancer

miR‐30c‐5p inhibits esophageal squamous cell carcinoma progression by repressing the PI3K/AKT signaling pathway

MicroRNA-181a-5p Prevents the Progression of Esophageal Squamous Cell Carcinoma in Vivo and in Vitro Via the MEK1-mediated ERK-MMP Signaling Pathway.

MiR-4739 Inhibits the Malignant Behavior of Esophageal Squamous Cell Carcinoma Cells Via the Homeobox C10/vascular Endothelial Growth Factor A/phosphatidylinositol 3-Kinase/akt Pathway.